These results confirm the interest to investigate maspin gene expression for the detection of circulating breast tumour cells or of submicroscopic lymph-node metastases in breast cancer patients (Merrie et al, 1999; Sabbatini et al, 2000). This evidence concerns the gene SERPINB5 and breast cancer.